These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10371493

  • 1. Big deal about a little insulin.
    Flier JS.
    Nat Med; 1999 Jun; 5(6):614-5. PubMed ID: 10371493
    [No Abstract] [Full Text] [Related]

  • 2. [Dihydroxybenzoquinones derivatives: orally-available insulin mimetics].
    Tanaka J.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():522-7. PubMed ID: 12387045
    [No Abstract] [Full Text] [Related]

  • 3. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [Abstract] [Full Text] [Related]

  • 4. Insulin and oral hypoglycaemics.
    Best JD.
    Aust Fam Physician; 1984 Oct; 13(10):747-53. PubMed ID: 6391448
    [Abstract] [Full Text] [Related]

  • 5. Insulin detemir. Novo Nordisk.
    Barlocco D.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
    [Abstract] [Full Text] [Related]

  • 6. Symposium of oral hypoglycemic agents on receptor and postreceptor actin of insulin.
    Diabetes Care; 1984 Apr; 7 Suppl 1():1-129. PubMed ID: 6376022
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacologic treatment of diabetes].
    De Montigny P, Clerc C, Descarpentries C.
    Perspect Infirm; 2006 Apr; 4(2):30-4. PubMed ID: 17184094
    [No Abstract] [Full Text] [Related]

  • 8. [Physiologic and physiopathologic implications of insulin-receptor interaction (II). Pathologic situations in which changes in insulin-receptor interaction are detected].
    Durán García S, Hernández Herrero C.
    Med Clin (Barc); 1984 Apr 14; 82(14):639-45. PubMed ID: 6376967
    [No Abstract] [Full Text] [Related]

  • 9. [Insulin receptors in diabetes mellitus].
    Tankova Ts.
    Vutr Boles; 1989 Apr 14; 28(6):8-12. PubMed ID: 2699128
    [No Abstract] [Full Text] [Related]

  • 10. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH, McNamara LA, Wu MS, Muise ES, Tan Y, Wood HB, Meinke PT, Thompson JR, Doebber TW, Berger JP, McCann ME.
    Eur J Pharmacol; 2008 Apr 14; 584(1):192-201. PubMed ID: 18346728
    [Abstract] [Full Text] [Related]

  • 11. [Insulin and its place in the therapy of diabetes mellitus types 1 and 2].
    Balabolkin MI.
    Probl Endokrinol (Mosk); 1990 Apr 14; 36(4):63-9. PubMed ID: 2235935
    [No Abstract] [Full Text] [Related]

  • 12. Update on systemic management of diabetes.
    Masharani U, Rushakoff RJ.
    Int Ophthalmol Clin; 2009 Apr 14; 49(2):13-33. PubMed ID: 19349784
    [No Abstract] [Full Text] [Related]

  • 13. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 14. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y, Ou-Yang JP, Wu K, Wang Y, Zhou YF, Wen CY.
    Acta Pharmacol Sin; 2005 Mar 03; 26(3):345-52. PubMed ID: 15715932
    [Abstract] [Full Text] [Related]

  • 15. [Action of metformin at and beyond insulin receptors. Studies in humans].
    Joffroy-Lavieuville M, Noël M.
    Journ Annu Diabetol Hotel Dieu; 1983 Mar 03; ():281-6. PubMed ID: 6358619
    [No Abstract] [Full Text] [Related]

  • 16. Inhaled insulin (exubera).
    Med Lett Drugs Ther; 2006 Jul 17; 48(1239):57-8. PubMed ID: 16841019
    [No Abstract] [Full Text] [Related]

  • 17. Medicine. Visfatin: a new adipokine.
    Hug C, Lodish HF.
    Science; 2005 Jan 21; 307(5708):366-7. PubMed ID: 15604359
    [No Abstract] [Full Text] [Related]

  • 18. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
    Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I, Vilella D, Díez MT, Pelaez F, Ruby C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG, Moller DE.
    Science; 1999 May 07; 284(5416):974-7. PubMed ID: 10320380
    [Abstract] [Full Text] [Related]

  • 19. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y, Clodfelder BJ, Shute AA, Irvin T, Vincent JB.
    J Biol Inorg Chem; 2002 Sep 07; 7(7-8):852-62. PubMed ID: 12203022
    [Abstract] [Full Text] [Related]

  • 20. Insulin analogues.
    Barnett AH, Owens DR.
    Lancet; 1997 Jan 04; 349(9044):47-51. PubMed ID: 8988131
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.